Viewing Study NCT00721266


Ignite Creation Date: 2025-12-24 @ 4:27 PM
Ignite Modification Date: 2026-01-01 @ 12:15 PM
Study NCT ID: NCT00721266
Status: COMPLETED
Last Update Posted: 2016-11-02
First Post: 2008-07-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose-Escalation Study of RO5083945 in Patients With Metastatic and/or Locally Advanced Malignant Epidermal Growth Factor Receptor (EGFR)+ Solid Tumors.
Sponsor: Hoffmann-La Roche
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2008-06
Start Date Type: None
Primary Completion Date: 2011-06
Primary Completion Date Type: ACTUAL
Completion Date: 2011-06
Completion Date Type: ACTUAL
First Submit Date: 2008-07-04
First Submit QC Date: None
Study First Post Date: 2008-07-24
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2016-11-01
Last Update Post Date: 2016-11-02
Last Update Post Date Type: ESTIMATED